| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/23/2007 | US20070197514 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity |
| 08/23/2007 | US20070197510 Nitriles and medicinal compositions containing the same as the active ingredient |
| 08/23/2007 | US20070197499 Pharmaceutical compounds |
| 08/23/2007 | US20070197493 Selenophene anti-tumor agents |
| 08/23/2007 | US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV) |
| 08/23/2007 | US20070197428 Novel indications of mannan-binding lectin (MBL) in the treatment of immuno-compromised individuals |
| 08/23/2007 | US20070197424 Glatiramer acetate for use as an immuno-modulatory agent |
| 08/23/2007 | US20070196445 Method for the Prevention and Treatment of Cachexia and Anorexia |
| 08/23/2007 | US20070196391 Mucosal boosting following parenteral priming |
| 08/23/2007 | US20070196377 polynucleotide; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection and treating stomach tumor; determining a disease, a pharmaceutical composition, and a reagent kit |
| 08/23/2007 | US20070196370 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/23/2007 | US20070196369 MHC-peptide complex binding ligands |
| 08/23/2007 | US20070196346 Poxvirus Vector Encoding Prostate Specific Antigens For Treatment Of Prostate Cancer |
| 08/23/2007 | US20070196339 Modified hpv e6 and e7 genes and proteins useful for vaccination |
| 08/23/2007 | US20070196336 Method For Constructing Recombinant Herpes Simplex Virus |
| 08/23/2007 | US20070196332 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/23/2007 | US20070196331 Methods and compositions for mobilizing stem cells |
| 08/23/2007 | US20070196276 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 08/23/2007 | DE20023910U1 Pharmakologisch wirksame Substanz zur Behandlung kardiovasulärer Erkrankungen Pharmacologically active substance for treating diseases kardiovasulärer |
| 08/23/2007 | DE102006008074A1 Behandlung von Krebs mit Geruchsrezeptor-Liganden Treatment of cancer with olfactory receptor ligands |
| 08/23/2007 | DE102006007433A1 Adjuvanz in Form einer Lipid-modifizierten Nukleinsäure Adjuvant in the form of a lipid-modified nucleic acid |
| 08/23/2007 | CA2642847A1 Dissolution aids for oral peptide delivery comprising a biguanide |
| 08/23/2007 | CA2642738A1 Pi-3 kinase inhibitors and methods of their use |
| 08/23/2007 | CA2642606A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/23/2007 | CA2641933A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 08/23/2007 | CA2641776A1 Pyrazoloquinolones are potent parp inhibitors |
| 08/23/2007 | CA2641384A1 Ibandronate regimen for treating metastatic bone pain |
| 08/23/2007 | CA2641254A1 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 08/23/2007 | CA2640509A1 Use of gallium(iii) complexes for the treatment of melanomas |
| 08/23/2007 | CA2640286A1 Use of local immune suppression to enhance oncolytic viral therapy |
| 08/23/2007 | CA2618628A1 Triazole compounds that modulate hsp90 activity |
| 08/22/2007 | EP1820861A2 C3B/C4B complement receptor-like molecules and uses thereof |
| 08/22/2007 | EP1820859A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1820514A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 08/22/2007 | EP1820513A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2007 | EP1820500A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 08/22/2007 | EP1820495A2 Microspheres for active embolization |
| 08/22/2007 | EP1820442A1 Noninvasive measurements of chemical substances |
| 08/22/2007 | EP1819728A2 Il-7 variants with reduced immunogenicity |
| 08/22/2007 | EP1819721A1 Microcin b17 analogs and methods for their preparation and use |
| 08/22/2007 | EP1819708A2 Substituted pteridines for treating inflammatory diseases |
| 08/22/2007 | EP1819697A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 08/22/2007 | EP1819696A1 Polymorphic forms of 6-2-(methylcarbamoyl)phenysulfanyl|-3-e-2-(pyridin-2-yl)ethenyl indazole |
| 08/22/2007 | EP1819688A2 Crystalline forms of docetaxel and processes for their preparation |
| 08/22/2007 | EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819669A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 08/22/2007 | EP1819359A2 Anti-integrin immunoconjugates, methods and uses |
| 08/22/2007 | EP1819339A1 A combination of n-(3-metoxy-5-methylpyrazin-2-yl)-2-(4-`1,3,4-oxadiazol-2-ylüphenyl)pyridine-3-sulphonamide and an anti-mitotic agent for the treatment of cancer |
| 08/22/2007 | EP1819331A1 Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof |
| 08/22/2007 | EP1819227A1 Pharmaceutical formulation of decitabine |
| 08/22/2007 | EP1734972A4 Method of treating solid tumors and leukemias using combination therapy of vitamin d and anti-metabolic nucleoside analogs |
| 08/22/2007 | EP1592431A4 Method of modulating il-6 |
| 08/22/2007 | EP1499320B1 Novel compounds |
| 08/22/2007 | EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
| 08/22/2007 | EP1406998B1 Liver engrafting cells, assays, and uses thereof |
| 08/22/2007 | EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 08/22/2007 | EP1326961B1 Compositions and methods for inducing specific cytolytic t cell responses |
| 08/22/2007 | EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS |
| 08/22/2007 | EP1190040B1 Herpes simplex virus expressing interleukin-12 gene and and its use for treating cancer |
| 08/22/2007 | EP1183256B1 Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/22/2007 | EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators |
| 08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 08/22/2007 | EP1150980B1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
| 08/22/2007 | EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors |
| 08/22/2007 | EP1124568B1 Polyspecific binding molecules and uses thereof |
| 08/22/2007 | EP0925069B1 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer |
| 08/22/2007 | EP0773950B1 Linked peptide nucleic acids |
| 08/22/2007 | CN1332978C Peptide as antagonist of VEGF receptor Flt-1 |
| 08/22/2007 | CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 08/22/2007 | CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/22/2007 | CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands |
| 08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
| 08/22/2007 | CN1332716C High molecular antineoplastic cisplatin medicine and preparation method thereof |
| 08/22/2007 | CN1332713C Methods for inhibiting brain tumor growth |
| 08/22/2007 | CN1332712C Oncolytic virus therapy |
| 08/22/2007 | CN1332706C Chinese medicine for treating liver diseases |
| 08/22/2007 | CN1332705C Chinese medicine for treating liver diseases |
| 08/22/2007 | CN1332687C Fatty acid synthetic enzyme inhibitor and its production method and application |
| 08/22/2007 | CN1332678C Tumour control pill |
| 08/22/2007 | CN1332672C Arsenic trioxide powder for injection |
| 08/22/2007 | CN1332668C Cepharanthine slow releasing preparation |
| 08/22/2007 | CN101023164A Cancerous disease modifying antibodies |
| 08/22/2007 | CN101023090A Prodrugs of HIV protease inhibitors |
| 08/22/2007 | CN101023086A Selected fused heterocyclics and uses thereof |
| 08/22/2007 | CN101023082A Fused pyrimidones useful in the treatment and the prevention of cancer |
| 08/22/2007 | CN101023080A Thiazolinone 4-monosubstituted quinolines |
| 08/22/2007 | CN101023079A Substituted hydantoins for the treatment of cancer |
| 08/22/2007 | CN101023074A Inhibitors of the interaction between MDM2 and P53 |
| 08/22/2007 | CN101023072A Piperidinyl targeting compounds that selectively bind integrins |
| 08/22/2007 | CN101022853A Mixture of catechins or polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (BPH) |
| 08/22/2007 | CN101022826A Bacterial compositions for the treatment of cancer |
| 08/22/2007 | CN101022809A Dihydropteridinones for the treatment of cancer diseases |
| 08/22/2007 | CN101022805A Process to prepare camptothecin derivatives |
| 08/22/2007 | CN101022790A Acid containing oxaliplatin formulations |
| 08/22/2007 | CN101020913A Sesquiterpene from marine microbe and possessing powerful antitumor activity |
| 08/22/2007 | CN101020719A Composite angelica polysaccharide and its prepn process and use |
| 08/22/2007 | CN101020716A Prepn and application of human tumor relevant N-jointing glycosyl chain monoclonal antibody |